Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY-NC-NDBMC public health

Effect of motivational interviews and peer education on adherence to pre-exposure prophylaxis among key populations in Kisangani: a randomized clinical trial.

4 affiliations
  1. 1Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of Congo. [email protected].
  2. 2Department of Public Health, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of Congo. [email protected].
  3. 3Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of Congo.
  4. 4Faculty of Medicine, University of Bunia, Bunia, Democratic Republic of Congo.

Abstract

Introduction

The present study aimed to evaluate the effect of motivational interviews and peer education on adherence to pre-exposure prophylaxis (PrEP) among key populations in Kisangani.Methods

This study utilizes a randomized controlled trial design to assess the effect of motivational interviewing and peer education on adherence to PrEP among key populations in Kisangani, DRC. The trial was conducted over 12 months, with data collection points at baseline and each month. In total, 141 participants agreed to participate in the study, and after evaluating the eligibility criteria, 126 met the criteria and were randomly assigned to the two study groups. Intervention group: Participants received monthly adherence counseling on PrEP, and motivational interviews with healthcare providers at the friendly centers. Peer educators also sensitized them on PrEP adherence within their residential and social environments.Control group

Participants were monitored on PrEP according to routine procedures at the friendly centers. Participants were randomly assigned to either the intervention or control group based on their order of enrollment. Data were collected at the friendly centers for key populations at enrollment visits and, during follow-up visits. Survival analysis was performed using Kaplan-Meier survival curves, and survival curves were compared using the Log-Rank test. Hazard ratios (HR) derived from the Cox model and their confidence intervals were presented.Result

We found that in the intervention group, 52 participants (82.5%) adhered to PrEP over the twelve months, compared to 16 participants (25.3%) in the control group (p < 0.0001). Without intervention, the risk of non-adherence was five times higher in the control group (HR 4.9, 95%CI [1.6937-14.2823], p = 0.003). Factors that strengthened adherence to PrEP included attending appointments for ARV refills (HR 0.15, 95% CI [0.0720-0.3404], p < 0.0001) and having adherence support (HR 0.26, 95% CI [0.1280-0.5482], p < 0.0001).Conclusion

Although the data confirm higher adherence in the intervention group, the high HIV incidence rate in the control group can be explained not only by the absence of the intervention but also by other factors related to the participants' lives that may have contributed to the higher seroconversion rate compared to the intervention group.Trial registration

PACTR202412535326702 registered in the Pan African clinical trials registry on December 2, 2024.

Related

  1. An LLM-based motivational interviewing training system for Japanese clinical education
    H Arashi, K Okumura, M Yasuda +2
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textEpidemiology & public healthPMCEurope PMC
  2. Single-dose/day versus extended antibiotic prophylaxis for elective urological surgery: a prospective randomized controlled trial
    Rishi Nayyar, Rajath S. Shetty, Anurag Kushwaha +8
    eClinicalMedicinePeer-reviewedCC BY 4.0General medicineCrossref
  3. An ecological analysis of legal policy environments and reported pre exposure prophylaxis availability for key populations in Asia Pacific countries
    Marcelo Amaral Mali, Abhishek Royal, Vaibhav Kumar +2
    Discover Social Science and HealthPeer-reviewedCC BYFull text1 citedInfectious diseaseDOAJ
  4. A randomized trial of grant writing coaching groups: Qualitative interviews revealing key elements of intervention efficacy
    J. Mendes, C. Wood, R. Jones +6
    bioRxivPreprintCC BYFull textEpidemiology & public healthbioRxiv
  5. Effectiveness of a Sequential Simulation and Online Learning Intervention on Psychiatric Mental Health Nurses’ Motivational Interviewing Knowledge, Confidence, and Skill Performance for Medication Adherence: A Cluster-randomized Controlled Trial
    Wen-Ling Hsieh, I-Hsien Li, Tsui-Mei Hung +2
    Asian Nursing ResearchPeer-reviewedCC BYFull textPhysiologyDOAJ
BibTeX
@article{tagototepungipame2026effect,
  title = {{Effect of motivational interviews and peer education on adherence to pre-exposure prophylaxis among key populations in Kisangani: a randomized clinical trial.}},
  author = {Alliance Tagoto-Tepungipame and John Panda-Lukongo and Serge Tonen-Wolyec and Dieu-Merci Mbumba-Lupaka and Salomon Batina-Agasa and Joris Likwela-Losimba},
  journal = {BMC public health},
  year = {2026},
  month = aug,
  doi = {10.1186/s12889-026-28740-z},
  url = {https://europepmc.org/article/MED/42958197},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Effect of motivational interviews and peer education on adherence to pre-exposure prophylaxis among key populations in Kisangani: a randomized clinical trial.
AU  - Alliance Tagoto-Tepungipame
AU  - John Panda-Lukongo
AU  - Serge Tonen-Wolyec
AU  - Dieu-Merci Mbumba-Lupaka
AU  - Salomon Batina-Agasa
AU  - Joris Likwela-Losimba
PY  - 2026
DA  - 2026/08/03
JO  - BMC public health
DO  - 10.1186/s12889-026-28740-z
UR  - https://europepmc.org/article/MED/42958197
AB  - Introduction  The present study aimed to evaluate the effect of motivational interviews and peer education on adherence to pre-exposure prophylaxis (PrEP) among key populations in Kisangani.Methods  This study utilizes a randomized controlled trial design to assess the effect of motivational interviewing and peer education on adherence to PrEP among key populations in Kisangani, DRC. The trial was conducted over 12 months, with data collection points at baseline and each month. In total, 141 participants agreed to participate in the study, and after evaluating the eligibility criteria, 126 met the criteria and were randomly assigned to the two study groups. Intervention group: Participants received monthly adherence counseling on PrEP, and motivational interviews with healthcare providers at the friendly centers. Peer educators also sensitized them on PrEP adherence within their residential and social environments.Control group  Participants were monitored on PrEP according to routine procedures at the friendly centers. Participants were randomly assigned to either the intervention or control group based on their order of enrollment. Data were collected at the friendly centers for key populations at enrollment visits and, during follow-up visits. Survival analysis was performed using Kaplan-Meier survival curves, and survival curves were compared using the Log-Rank test. Hazard ratios (HR) derived from the Cox model and their confidence intervals were presented.Result  We found that in the intervention group, 52 participants (82.5%) adhered to PrEP over the twelve months, compared to 16 participants (25.3%) in the control group (p < 0.0001). Without intervention, the risk of non-adherence was five times higher in the control group (HR 4.9, 95%CI [1.6937-14.2823], p = 0.003). Factors that strengthened adherence to PrEP included attending appointments for ARV refills (HR 0.15, 95% CI [0.0720-0.3404], p < 0.0001) and having adherence support (HR 0.26, 95% CI [0.1280-0.5482], p < 0.0001).Conclusion  Although the data confirm higher adherence in the intervention group, the high HIV incidence rate in the control group can be explained not only by the absence of the intervention but also by other factors related to the participants' lives that may have contributed to the higher seroconversion rate compared to the intervention group.Trial registration  PACTR202412535326702 registered in the Pan African clinical trials registry on December 2, 2024.
SN  - 1471-2458
ER  -